A working UAE Tatmeen solution for serialization, aggregation and reporting — already implemented and used by customers supplying the UAE pharmaceutical market.
SoftGroup provides pharmaceutical serialization, aggregation and regulatory connectivity solutions that help companies manage reporting to national track-and-trace systems, including UAE Tatmeen.
This page explains UAE Tatmeen connectivity and how SoftGroup supports serialization, aggregation and reporting for companies supplying the UAE pharmaceutical market.
UAE Tatmeen connectivity is the ability to exchange accurate serialization, aggregation, product, batch and shipment-related data with Tatmeen as part of pharmaceutical track-and-trace operations in the UAE market.Global Regulatory Reporting | Level 5
What is UAE Tatmeen?
Tatmeen is the UAE’s national track-and-trace platform for pharmaceuticals and medical products.
For companies supplying the UAE market, Tatmeen is not only a technical connection to be completed once. It becomes part of the daily serialization, traceability and reporting process — where product data, batch events, aggregation data, shipments and partner activities need to remain accurate over time.
Why Tatmeen connectivity matters operationally
Connecting to Tatmeen is an important milestone. Keeping the process stable after go-live is the ongoing responsibility.
Product master data changes. Packaging configurations change. Batches move through production, packaging and distribution. Shipments are prepared and transferred. Supply-chain partners may be added, changed or removed.
Each of these operational changes can affect the accuracy of serialization and reporting data.
A Tatmeen connection that works at go-live but is not maintained under daily operational volume can create reporting gaps, delays and avoidable compliance risk.
That is why UAE Tatmeen connectivity should be treated as part of the operating model for pharmaceutical traceability — not only as a one-time IT project.
What pharmaceutical companies tell us they need
“We need a single platform, we cannot manage multiple vendors across our markets.”
— Operations Manager, European pharmaceutical company
“We need reporting that keeps working as products, partners, and markets change.”
— European pharmaceutical company
Who needs to be ready?
UAE Tatmeen connectivity is relevant for pharmaceutical companies and supply-chain stakeholders involved in products supplied to the UAE market, including:
- Pharmaceutical manufacturers
- Marketing Authorization Holders
- CMOs and CPOs
- Scientific offices and licensed agents
- Distributors and logistics partners
- Serialization managers
- Regulatory affairs teams
- QA teams
- IT and supply-chain teams
Each role may interact with different parts of the serialization and reporting process, but the operational goal is the same: accurate data, stable connectivity and reliable reporting.
How SoftGroup supports UAE Tatmeen connectivity
SoftGroup® has a working UAE Tatmeen solution, already implemented and used by customers supplying the UAE pharmaceutical market.
The solution supports the operational processes behind Tatmeen reporting, including serialization data, aggregation data, product master data, batch and shipment-related events, partner coordination and ongoing connectivity monitoring.
It is part of SoftGroup’s broader serialization and regulatory connectivity infrastructure, built on 22+ years of experience in pharmaceutical serialization and traceability and used by 145+ customers across 43+ regulated markets.
For companies operating in more than one market, this matters. UAE Tatmeen is often not the only authority connection a pharmaceutical company needs to manage. Serialization teams may also need to maintain reporting processes for EU FMD / EMVS and other national systems.
SoftGroup helps companies manage these requirements through one consistent serialization and traceability approach.
Operational capabilities
SoftGroup’s UAE Tatmeen connectivity supports practical, day-to-day operational needs such as:
- Serialization and aggregation data readiness for products supplied to the UAE market
- Product master data accuracy across SKUs, packaging changes and registrations
- Batch and shipment-related event handling
- Partner and supply-chain coordination with CMOs, distributors and logistics partners
- Reporting processes connected to Tatmeen
- Exception handling and status monitoring
- Connectivity stability under daily operational volume
- Support for companies managing Tatmeen alongside other regulated markets
- Serialization and aggregation data readiness for products supplied to the UAE market
- Product master data accuracy across SKUs, packaging changes and registrations
- Batch and shipment-related event handling
- Partner and supply-chain coordination with CMOs, distributors and logistics partners
- Reporting processes connected to Tatmeen
- Exception handling and status monitoring
- Connectivity stability under daily operational volume
- Support for companies managing Tatmeen alongside other regulated markets
Why choose SoftGroup?
SoftGroup does not treat UAE Tatmeen as an isolated implementation.
It is one connection within a wider pharmaceutical serialization, aggregation and regulatory reporting environment. This allows companies to manage Tatmeen as part of their broader traceability infrastructure, instead of maintaining disconnected country-by-country processes.
For UAE Tatmeen specifically, SoftGroup provides a working solution already used by customers supplying the UAE market — not a concept being built for the first time.
FAQ
What is UAE Tatmeen?
UAE Tatmeen connectivity is relevant for pharmaceutical companies and supply-chain stakeholders involved in products supplied to the UAE market, including manufacturers, MAHs, CMOs, CPOs, scientific offices, licensed agents, distributors and logistics partners.
Who needs UAE Tatmeen connectivity?
Tatmeen is the UAE’s national track-and-trace platform for pharmaceuticals and medical products.
What data is involved in Tatmeen reporting?
Tatmeen is the UAE’s national track-and-trace platform for pharmaceuticals and medical products.
Is UAE Tatmeen connectivity a one-time project?
No. Initial connectivity is a technical milestone, but Tatmeen reporting remains an ongoing operational process. Product data, batches, shipments and partners continue to change after go-live.
Does SoftGroup support UAE Tatmeen?
Yes. SoftGroup has a working UAE Tatmeen solution, already implemented and used by customers supplying the UAE pharmaceutical market.
Can SoftGroup support companies already connected to Tatmeen?
Yes. SoftGroup can support companies preparing for UAE Tatmeen connectivity as well as companies that are already connected and want to strengthen daily reporting stability, data accuracy and operational monitoring.
Can SoftGroup support Tatmeen alongside other regulated markets?
Yes. SoftGroup supports pharmaceutical serialization and regulatory connectivity across 43+ regulated markets, helping companies manage UAE Tatmeen together with other national authority requirements.
Keep UAE Tatmeen reporting stable after go-live
UAE Tatmeen compliance does not end with the initial connection.
If your teams are preparing to connect, already connected, or managing Tatmeen as part of a wider multi-market serialization environment, talk to SoftGroup about what a working, in-production Tatmeen connection looks like in practice.
